ICMR approaches experts panel to approve testing of cancer drug acalabrutinib for Covid treatment

ICMR’s National AIDS Research Institute (NARI) had presented a proposal to the Subject Expert Committee (SEC) formed to review Covid related proposals seeking to amend Solidarity’s ongoing protocol by adding a trial arm to test acalabrutinib.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2GZd6Nr
via IFTTT